Lazard Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,145
| Closed | -$65K | – | 2328 |
|
|
2021
Q3 | $65K | Buy |
+1,145
| New | +$65K | ﹤0.01% | 1565 |
|
|
2020
Q4 | – | Sell |
-985
| Closed | -$45K | – | 1875 |
|
|
2020
Q3 | $45K | Sell |
985
-201
| -17% | -$9.18K | ﹤0.01% | 1217 |
|
|
2020
Q2 | $59K | Buy |
1,186
+176
| +17% | +$8.76K | ﹤0.01% | 1184 |
|
|
2020
Q1 | $51K | Buy |
1,010
+260
| +35% | +$13.1K | ﹤0.01% | 1164 |
|
|
2019
Q4 | $46K | Buy |
750
+569
| +314% | +$34.9K | ﹤0.01% | 1076 |
|
|
2019
Q3 | $10K | Buy |
+181
| New | +$10K | ﹤0.01% | 1304 |
|
|
2018
Q2 | – | Sell |
-19,058
| Closed | -$1.54M | – | 1049 |
|
|
2018
Q1 | $1.54M | Buy |
19,058
+6,990
| +58% | +$565K | ﹤0.01% | 672 |
|
|
2017
Q4 | $708K | Buy |
+12,068
| New | +$708K | ﹤0.01% | 731 |
|
|
2015
Q1 | – | Sell |
-93,715
| Closed | -$4.77M | – | 1144 |
|
|
2014
Q4 | $4.77M | Buy |
93,715
+88,120
| +1,575% | +$4.48M | 0.01% | 548 |
|
|
2014
Q3 | $221K | Buy |
+5,595
| New | +$221K | ﹤0.01% | 827 |
|